Cargando…

Genetic alterations, RNA expression profiling and DNA methylation of HMGB1 in malignancies

The high mobility group box 1 (HMGB1) is a potential biomarker and therapeutic target in various human diseases. However, a systematic, comprehensive pan‐cancer analysis of HMGB1 in human cancers remains to be reported. This study analysed the genetic alteration, RNA expression profiling and DNA met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shoukai, Qian, Lingmei, Ma, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344825/ https://www.ncbi.nlm.nih.gov/pubmed/35765707 http://dx.doi.org/10.1111/jcmm.17454

Ejemplares similares

Comprehensive analysis of the expression and prognosis for APOE in malignancies: A pan-cancer analysis
por: YU, SHOUKAI, et al.
Publicado: (2022)

Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis
por: Chai, Peiwei, et al.
Publicado: (2020)

Altered DNA Methylation of Long Noncoding RNA uc.167 Inhibits Cell Differentiation in Heart Development
por: Yin, Anwen, et al.
Publicado: (2018)

Exosomal HMGB1 Promoted Cancer Malignancy
por: Wang, Jiaan-Der, et al.
Publicado: (2021)

Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma
por: Hua, Yang, et al.
Publicado: (2017)

Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes
por: Zheng, Wen-Jie, et al.
Publicado: (2018)

Genetic and Epigenetic Alterations Induced by Pesticide Exposure: Integrated Analysis of Gene Expression, microRNA Expression, and DNA Methylation Datasets
por: Giambò, Federica, et al.
Publicado: (2021)

Genetic Alterations and Transcriptional Expression of m(6)A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma
por: Zhu, Gui-Qi, et al.
Publicado: (2020)

HMGB1 contributes to SASH1 methylation to attenuate astrocyte adhesion
por: Wu, Ronghua, et al.
Publicado: (2019)

MYTH: An algorithm to score intratumour heterogeneity based on alterations of DNA methylation profiles
por: Liu, Qian, et al.
Publicado: (2021)

HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC
por: Dong, Jing, et al.
Publicado: (2022)

Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles
por: Mishra, Nitish Kumar, et al.
Publicado: (2020)

A Portrait of Ribosomal DNA Contacts with Hi-C Reveals 5S and 45S rDNA Anchoring Points in the Folded Human Genome
por: Yu, Shoukai, et al.
Publicado: (2016)

The long-range interaction map of ribosomal DNA arrays
por: Yu, Shoukai, et al.
Publicado: (2018)

Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA
por: Zhang, Yang, et al.
Publicado: (2016)

MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation
por: Yang, Yu, et al.
Publicado: (2015)

Structural Characteristics of High-Mobility Group Proteins HMGB1 and HMGB2 and Their Interaction with DNA
por: Starkova, Tatiana Y., et al.
Publicado: (2023)

Alterations in DNA methylation profiles in cancellous bone of postmenopausal women with osteoporosis
por: Zhou, Yu, et al.
Publicado: (2020)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies
por: Niktoreh, Naghmeh, et al.
Publicado: (2023)

An Integrated Analysis of the Genome-Wide Profiles of DNA Methylation and mRNA Expression Defining the Side Population of a Human Malignant Mesothelioma Cell Line
por: Kim, Myung-Chul, et al.
Publicado: (2016)

DNA-methylation profiling distinguishes malignant melanomas from benign nevi
por: Conway, Kathleen, et al.
Publicado: (2011)

Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
por: Tabata, Chiharu, et al.
Publicado: (2013)

Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases
por: Pilzweger, Christin, et al.
Publicado: (2015)

HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
por: Wang, Yanbin, et al.
Publicado: (2019)

Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB
por: Xie, Biao, et al.
Publicado: (2016)

Maternal Inulin Supplementation Alters Hepatic DNA Methylation Profile and Improves Glucose Metabolism in Offspring Mice
por: Zhang, Qian, et al.
Publicado: (2020)

Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma
por: Wang, Jian-Yao, et al.
Publicado: (2021)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

Osteoarthritis related epigenetic variations in miRNA expression and DNA methylation
por: Jin, Lingpeng, et al.
Publicado: (2023)

Nuclease deficiencies alter plasma cell-free DNA methylation profiles
por: Han, Diana S.C., et al.
Publicado: (2021)

HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer
por: Huang, Bi-Fei, et al.
Publicado: (2018)

Mechanism of DNA flexibility enhancement by HMGB proteins
por: Zhang, Jingyun, et al.
Publicado: (2009)

Integrated Epigenome Profiling of Repressive Histone Modifications, DNA Methylation and Gene Expression in Normal and Malignant Urothelial Cells
por: Dudziec, Ewa, et al.
Publicado: (2012)

Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression
por: Wu, Deyao, et al.
Publicado: (2019)

Long noncoding RNA BS-DRL1 modulates the DNA damage response and genome stability by interacting with HMGB1 in neurons
por: Lou, Min-Min, et al.
Publicado: (2021)

Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer
por: Ma, Ying, et al.
Publicado: (2023)

Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients
por: Pacholewska, Alicja, et al.
Publicado: (2021)

HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIα
por: Štros, Michal, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_uk7d3ajtgmptniio5f4lsopjj6